The PCPT Study: Perspectives of an Interested Urologist

    December 2004 in “ Annales d Urologie ”
    R. Fourcade
    TLDR Finasteride may reduce prostate cancer risk.
    The Prostate Cancer Prevention Trial (PCPT) was a significant clinical study that explored the potential of reducing prostate cancer incidence through the daily intake of 5 mg of finasteride over 7 years. The study, published in the New England Journal of Medicine, was complex in its methodology. It aimed to highlight the key methodological aspects, present notable results, and discuss possible clinical applications in everyday urological practice.
    Discuss this study in the Community →